An injectable vitreous substitute with sustained release of metformin for enhanced uveal melanoma immunotherapy

Post time 2024-4-28 00:09:11

journal：Biomaterials Science

Authors：Muyue Yang; Jipeng Li; Zeyang Liu; Haiyang Zhang; Jin Liu; Yan Liu; Ai Zhuang; Huifang Zhou; Ping Gu; Xianqun Fan

Published date：--

DOI：10.1039/d2bm01058e

PDF link：http://pubs.rsc.org/en/content/articlepdf/2022/BM/D2BM01058E

Article link：http://dx.doi.org/10.1039/d2bm01058e

Article Source：Royal Society of Chemistry (RSC)。

Remark：

Post time 2024-4-28 00:09:12

: This post has been completed
Completed attachments will be deleted within 24 hours.

[RSC] An injectable vitreous substitute with sustained release of metformin for enhanced uveal melanoma immunotherapy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[RSC] An injectable vitreous substitute with sustained release of metformin for enhanced uveal melanoma immunotherapy Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[RSC] An injectable vitreous substitute with sustained release of metformin for enhanced uveal melanoma immunotherapy